Follow
Vijaya B Joshi, PhD
Vijaya B Joshi, PhD
Zoetis
Verified email at zoetis.com
Title
Cited by
Cited by
Year
Biodegradable particles as vaccine delivery systems: size matters
VB Joshi, SM Geary, AK Salem
The AAPS journal 15, 85-94, 2013
2702013
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial
A Woodcock, J Vestbo, ND Bakerly, J New, JM Gibson, S McCorkindale, ...
The Lancet 390 (10109), 2247-2255, 2017
1302017
Study of anti-inflammatory, analgesic and antipyretic activities of seeds of Hyoscyamus niger and isolation of a new coumarinolignan
S Begum, B Saxena, M Goyal, R Ranjan, VB Joshi, CV Rao, ...
Fitoterapia 81 (3), 178-184, 2010
1272010
Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung
KLS Worthington, A Adamcakova-Dodd, A Wongrakpanich, ...
Nanotechnology 24 (39), 395101, 2013
962013
Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses
VB Joshi, SM Geary, AK Salem
Human vaccines & immunotherapeutics 9 (12), 2584-2590, 2013
902013
Eugenol as an anti-stress agent: modulation of hypothalamic–pituitary–adrenal axis and brain monoaminergic systems in a rat model of stress
D Garabadu, A Shah, A Ahmad, VB Joshi, B Saxena, G Palit, ...
Stress 14 (2), 145-155, 2011
862011
Biodegradable Microparticles Loaded with Doxorubicin and CpG ODN for In Situ Immunization Against Cancer
A Makkouk, VB Joshi, A Wongrakpanich, CD Lemke, BP Gross, AK Salem, ...
The AAPS journal 17, 184-193, 2015
722015
Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy
VB Joshi, A Adamcakova-Dodd, X Jing, A Wongrakpanich, ...
The AAPS journal 16, 975-985, 2014
582014
Tumor lysate-loaded biodegradable microparticles as cancer vaccines
VB Joshi, SM Geary, BP Gross, A Wongrakpanich, LA Norian, AK Salem
Expert review of vaccines 13 (1), 9-15, 2014
492014
Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles
VB Joshi, SM Geary, BR Carrillo-Conde, B Narasimhan, AK Salem
Acta biomaterialia 9 (3), 5583-5589, 2013
442013
Intracellular release of 17-β estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic …
L Hong, Y Krishnamachari, D Seabold, V Joshi, G Schneider, AK Salem
Tissue Engineering Part C: Methods 17 (3), 319-325, 2011
382011
Diaminosulfide based polymer microparticles as cancer vaccine delivery systems
SM Geary, Q Hu, VB Joshi, NB Bowden, AK Salem
Journal of controlled release 220, 682-690, 2015
372015
Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human …
L Hong, N Wei, V Joshi, Y Yu, NJ Kim, Y Krishnamachari, Q Zhang, ...
Tissue Engineering Part A 18 (7-8), 775-784, 2012
322012
Antigen-coated poly α-hydroxy acid based microparticles for heterologous prime-boost adenovirus based vaccinations
CD Lemke, SM Geary, VB Joshi, AK Salem
Biomaterials 34 (10), 2524-2529, 2013
192013
The absence of CpG in plasmid DNA–chitosan polyplexes enhances transfection efficiencies and reduces inflammatory responses in murine lungs
A Wongrakpanich, A Adamcakova-Dodd, W Xie, VB Joshi, KA Mapuskar, ...
Molecular pharmaceutics 11 (3), 1022-1031, 2014
182014
Three steps to breaking immune tolerance to lymphoma: a microparticle approach
A Makkouk, VB Joshi, CD Lemke, A Wongrakpanich, AK Olivier, ...
Cancer immunology research 3 (4), 389-398, 2015
162015
Glucocorticoid receptor antagonist and siRNA prevent senescence of human bone marrow mesenchymal stromal cells in vitro
N Wei, Y Yu, V Joshi, T Schmidt, F Qian, AK Salem, C Stanford, L Hong
Cell and tissue research 354, 461-470, 2013
142013
Production of antigen-loaded biodegradable nanoparticles and uptake by dendritic cells
VB Joshi, SM Geary, AK Salem
Cancer Vaccines: Methods and Protocols, 453-466, 2014
82014
Poly (galactaramidoamine) is an efficient cationic polymeric non-viral vector with low cytotoxicity for transfecting human embryonic kidney (HEK293) and murine macrophage …
A Wongrakpanich, VB Joshi, AK Salem
Pharmaceutical development and technology 18 (5), 1255-1258, 2013
52013
Three Steps to Breaking Immune Tolerance: A Microparticle Approach
A Makkouk, VB Joshi, CD Lemke, A Wongrakpanich, AK Olivier, ...
Blood 124 (21), 4504, 2014
42014
The system can't perform the operation now. Try again later.
Articles 1–20